Eliquis Price Changes Are Coming. Here’s What Patients Need to Know

Bristol Myers Squibb and Pfizer are slashing the price of Eliquis for cash-paying patients. Here’s what it means for you and how to find the best price.

By EveryDose

|

Eliquis hero image

If you take Eliquis (apixaban), there’s major pricing news you should know about. Starting in early 2026, the makers of Eliquis — Bristol Myers Squibb and Pfizer — will begin selling the medication directly to U.S. patients at a much lower cash price.

Here’s what that means for you, whether you’re paying out-of-pocket, using insurance, or looking for ways to save.

What is Eliquis?

Eliquis (apixaban) is a prescription blood thinner used to:

  • Reduce the risk of stroke and blood clots in people with atrial fibrillation (not caused by a heart valve problem)
  • Treat deep vein thrombosis (DVT) and pulmonary embolism (PE)
  • Prevent blood clots after hip or knee replacement surgery

It’s one of the most commonly prescribed medications in the U.S., but also one of the most expensive — especially for those without good insurance coverage.

What’s Changing?

On July 17, 2025, the companies announced that starting January 2026, they’ll launch a new direct-to-patient program that drastically lowers the cash price of Eliquis to $160 per month for most people.

That’s a significant drop from current list prices, which can be more than $500 per month without insurance.

This change comes ahead of expected generic competition in 2028 and is designed to make the brand-name drug more accessible to uninsured and underinsured patients.

What If You Take Eliquis Today?

If you’re currently prescribed Eliquis, here’s what to consider:

1. Do you have insurance?

  • Insurance may still be cheaper. Most insurance plans — including Medicare Part D — cover Eliquis, often at a lower out-of-pocket cost than $160/month.
  • But coverage varies, so check your plan’s formulary or ask your pharmacist what you’ll pay.

2. Do you pay cash or have a high deductible?

  • The new $160/month direct price could be a better deal than what you’re paying now.
  • But this new program won’t launch until early 2026, so you’ll still need to explore other savings options in the meantime.

How to Save on Eliquis Right Now

Until the new direct-to-patient program begins, here are your options for lowering your Eliquis costs:

1. Use the EveryDose Savings Card

Search for the lowest local pharmacy prices at www1.singlecare.com/everydose.
You can download, text, or print the coupon and use it at the pharmacy instead of insurance (if it’s cheaper).

2. Check the Eliquis Manufacturer Assistance Program

Bristol Myers Squibb offers help for eligible patients through the Pfizer RxPathways program.
You may qualify for free medication if you meet income and insurance requirements.
Learn more at: www.pfizerrxpathways.com

3. Talk to Your Pharmacist or Doctor

Your care team may know about patient assistance programs, generic alternatives (once available), or ways to switch to a different therapy that’s more affordable.

What to Expect in 2026

Once the $160/month direct price becomes available:

  • You won’t need insurance to qualify — anyone can access the price.
  • It may be especially helpful for patients in the coverage gap or without drug benefits.
  • Details on how to enroll will likely be released closer to the launch — we’ll keep you updated in the EveryDose app.

Final Tips

  • Compare your options. Use insurance if it gives you the best price, but don’t assume it’s the cheapest.
  • Stay adherent. Don’t skip doses or ration — Eliquis is essential to prevent serious complications like stroke or blood clots.
  • Set medication reminders in the EveryDose app to stay on track and keep your routine stress-free.

💡 EveryDose is here to help you navigate medication costs and stay informed when things change. We’ll continue to monitor Eliquis pricing and alert you in the app when the new pricing option becomes available.

Disclaimer: Eliquis® is a registered trademark of Bristol-Myers Squibb Company and Pfizer Inc. All rights reserved. EveryDose is not affiliated with, sponsored by, or endorsed by Bristol-Myers Squibb, Pfizer, or the makers of Eliquis. This content is for informational purposes only and does not constitute medical or financial advice.